IL2 and neoplasm: Tumor infiltration and signaling pathway for immune modulating cytokine IL-2 had a strong negative correlation with KIT expression, which is in line with our conclusion that KIT expression in neuroblastomas is not driven by immune infiltration (Figure 1C).